Article Information
History
- November 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ashley RG Libby1,2,†,
- Ivana Vasic2,3,†,
- David A Joy2,3,
- Martina Z Krakora2,
- Fredrico N Mendoza-Camacho2,
- Bruce R Conklin2,4,5,6 and
- Todd C McDevitt2,7,*
- 1Developmental and Stem Cell Biology PhD Program, University of California, San Francisco, CA
- 2Gladstone Institutes, San Francisco, CA
- 3UC Berkeley-UC San Francisco Graduate Program in Bioengineering, San Francisco, CA
- 4UCSF Department of Ophthalmology, 10 Koret Way, San Francisco, CA, 94143-0730
- 5Innovative Genomics Institute, 2151 Berkeley Way, Berkeley, CA 94720
- 6UCSF Department of Medicine, 535 Mission Bay Blvd South, San Francisco, CA 94158
- 7Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA
- ↵*Corresponding author: todd.mcdevitt{at}gladstone.ucsf.edu
↵† These authors contributed equally to this work.
Posted November 03, 2020.
Silencing of E-cadherin in induced human pluripotent stem cells promotes extraembryonic fates accompanying multilineage differentiation
